NCT03051308 is a NA clinical trial of NPT and UW Solution in Parathyroid Allotransplantation, sponsored by SB Istanbul Education and Research Hospital.

Who is sponsoring NCT03051308?

NCT03051308 is sponsored by SB Istanbul Education and Research Hospital.

What drugs are being tested in NCT03051308?

Interventions in NCT03051308: NPT and UW Solution.

What condition does NCT03051308 study?

NCT03051308 studies Parathyroid Allotransplantation.

Is NCT03051308 still recruiting?

NCT03051308 is currently status unknown. Last updated 13 February 2017.

Last reviewed 2017-02-13 · How we verify

NCT03051308

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation

Status unknown NA Last updated 13 February 2017

What this trial tests

NA trial testing NPT and UW Solution in Parathyroid Allotransplantation in 7 participants. Status unknown.

Timeline

1 March 2017

Primary endpoint
1 June 2017

1 July 2017

Quick facts

Lead sponsor	SB Istanbul Education and Research Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	7
Start date	1 March 2017
Primary completion	1 June 2017
Estimated completion	1 July 2017
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

NPT and UW Solution

Conditions studied

Parathyroid Allotransplantation — all drugs for Parathyroid Allotransplantation →

Sponsor

SB Istanbul Education and Research Hospital

Who can join

Adults 18 to 80, any sex, with Parathyroid Allotransplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare the functionality of new parathyroid transport solution (NPTS) with University of Wisconsin Solution (UW) on parathyroid glands. Also assess its effects on cell viability, parathormone (PTH) secretion, calcium-sensing receptor (CaSR) and vitamin D receptor (VDR) levels during cold ischemia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other SB Istanbul Education and Research Hospital trials

Trials by the same sponsor.

NCT07071571 — New Intraoperative Nerve Monitoring Device · NA · not yet recruiting
NCT06873087 — Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema · Phase 4 · completed
NCT03780998 — Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases · unknown
NCT04940169 — Anterior Cruciate Ligament Reconstruction Made With Hamstring Tendon And Quadriceps Tendon Autografts · NA · completed
NCT04230343 — Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03051308 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by SB Istanbul Education and Research Hospital
Last refreshed: 13 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03051308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing